50 Mg Dasatinib Tablets

Name: 50 Mg Dasatinib Tablets
Brand: NEETCO BIOPHARMA
Price: 2500 INR
Availability: InStock

Price 2500 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

50 Mg Dasatinib Tablets Specification

Indication
Treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

Salt Composition
Dasatinib 50 mg

Dosage Form
Tablet

Feature
Targeted oral tyrosine kinase inhibitor for leukemia

Ingredients
Dasatinib and excipients

Application
Oral administration in cancer therapy

Physical Color/Texture
White to off-white, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, in original packaging, away from moisture

Shelf Life
24 months

About 50 Mg Dasatinib Tablets

Dasatrue 50 (Dasatinib 50 mg) presents a sterling choice for healthcare providers seeking a cost-effective, commanding solution in cancer therapy. This opulent oral medication comes in bottles of 60 tablets, formulated for reliable access across global markets. With favorable reviews from medical professionals, Dasatrue 50 stands out as a targeted tyrosine kinase inhibitor for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Its white to off-white film-coated tablets are odorless, prescription-only, and designed for ease of administration. Store securely at controlled room temperature for optimal efficacy.

Precision-Crafted Oral Therapy for Leukemia

Dasatrue 50 is an oral prescription tablet, precisely formulated for the treatment of CML and Ph+ ALL. Suitable for adults and children diagnosed with these conditions, Dasatrue 50 offers targeted action as a tyrosine kinase inhibitor. The tablets are film-coated and easy to ingest, making them a smart choice in continuous cancer care. Their odorless and stable physical characteristics ensure patient comfort and compliance during long-term use.

Reliable Supply and Recognized Value in the Global Market

Our estimate for supply ability remains robust, with timely arrival to key international markets, including India, Middle East, Africa, and Southeast Asia. Dasatrue 50 upholds stringent certifications to guarantee quality and authenticity. Its commanding presence in the oncology field supports reputable market value, trusted by distributors and healthcare professionals alike. Secure packaging and rigorous quality assurance accompany every bottle, affirming a consistent supply experience worldwide.

FAQ's of 50 Mg Dasatinib Tablets:

Q: How should Dasatrue 50 mg Dasatinib Tablets be administered?

A: Dasatrue 50 mg tablets are administered orally, as directed by a physician, typically once daily with or without food. Always follow your doctor's instructions regarding dosage and timing.

Q: What is Dasatrue 50 used for?

A: Dasatrue 50 is indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and children.

Q: When should Dasatrue 50 not be used?

A: Dasatrue 50 should not be used if you have a known hypersensitivity to dasatinib or any of its components. Always inform your healthcare provider of any allergies or prior reactions to medications.

Q: Where should Dasatrue 50 mg tablets be stored?

A: Store Dasatrue 50 tablets in their original packaging, at a controlled room temperature between 20-25C (68-77F), away from moisture, and always below 30C.

Q: What are common side effects of Dasatrue 50?

A: Common side effects include myelosuppression, fluid retention, diarrhea, headache, rash, and fatigue. Contact your healthcare provider if any of these symptoms persist or worsen.

Q: How does Dasatrue 50 benefit leukemia patients?

A: Dasatrue 50 acts as a targeted tyrosine kinase inhibitor, which interferes with leukemia cell growth, providing an effective and modern approach to managing specific types of leukemia.

Tell us about your requirement